1 Streptococcus pneumoniae thoracic empyema in children: rapid diagnosis by using the Binax NOW immunochromatographic membrane test in pleural fluids

2 Management of nonsevere pneumonia in military trainees with the urinary antigen test for Streptococcus pneumoniae: an innovative approach to targeted therapy

3 [COVID-19: The Perspective Of Nephrology]

4 Quantitative shedding patterns of respiratory syncytial virus in infants

5 Contribution of a urinary antigen assay (Binax NOW) to the early diagnosis of pneumococcal pneumonia

6 Assessment of Community-Level Disparities in Coronavirus Disease 2019 (COVID-19) Infections and Deaths in Large US Metropolitan Areas

7 Respiratory syncytial virus upper respiratory tract illnesses in adult blood and marrow transplant recipients: combination therapy with aerosolized ribavirin and intravenous immunoglobulin

8 Validation of immunoglobulin G enzyme-linked immunosorbent assay for antibodies to pneumococcal surface adhesin A in the diagnosis of pneumococcal pneumonia among adults in Kenya

9 High pneumococcal DNA loads are associated with mortality in Malawian children with invasive pneumococcal disease

10 Antigen detection for the diagnosis of pneumonia

11 Performance of the Binax NOW Streptococcus pneumoniae urinary antigen assay for diagnosis of pneumonia in children with underlying pulmonary diseases in the absence of acute pneumococcal infection

12 Evaluation of polymerase chain reaction for diagnosis of pneumococcal pneumonia

13 Immunodetection of pneumolysin in human urine by ELISA

14 Etiology of community-acquired pneumonia in 254 hospitalized children

15 Diagnosis of bacteremic pneumococcal pneumonia by amplification of pneumolysin gene fragment in serum

16 A cluster of ecthyma outbreaks caused by a single clone of invasive and highly infective Streptococcus pyogenes

17 Respiratory syncytial virus infections in autologous blood and marrow transplant recipients with breast cancer: combination therapy with aerosolized ribavirin and parenteral immunoglobulins

18 A trial of a 9-valent pneumococcal conjugate vaccine in children with and those without HIV infection

19 Epidemiology of respiratory syncytial virus infection in Washington, D.C. I. Importance of the virus in different respiratory tract disease syndromes and temporal distribution of infection

20 Assessment of a rapid urinary antigen detection by an immunochromatographic test for diagnosis of pneumococcal infection in children

21 Prospective study of the usefulness of sputum Gram stain in the initial approach to community-acquired pneumonia requiring hospitalization

22 Etiology of community-acquired pneumonia: impact of age, comorbidity, and severity

23 Community acquired pneumonia--a prospective UK study

24 Community-acquired pneumonia: etiology, epidemiology, and outcome at a teaching hospital in Argentina

25 Diagnosis of pneumococcal pneumonia by psaA PCR analysis of lung aspirates from adult patients in Kenya

26 [COVID-19: a cardiological point-of-view]

27 Evaluation of the polymerase chain reaction method for detection of Streptococcus pneumoniae DNA in pleural fluid samples

28 Pneumolysin polymerase chain reaction for diagnosis of pneumococcal pneumonia and empyema in children

29 Factors influencing fluoroquinolone resistance

30 Community respiratory virus infections in immunocompromised patients with cancer

31 Telemedicine in the Time of Coronavirus

32 The immunologic response to infection with respiratory syncytial virus in infants

33 Immunopathologic mechanisms in lower respiratory tract disease of infants due to respiratory syncytial virus

34 Molecular genetic methods in the diagnosis of lower respiratory tract infections

35 Cell-free and cell-bound antibody in nasal secretions from infants with respiratory syncytial virus infection

36 Evaluation of a rapid immunochromatographic test for detection of Streptococcus pneumoniae antigen in urine samples from adults with community-acquired pneumonia

37 [Management of obstructive sleep apnea during COVID-19 pandemic]

38 An advisory by the association of radiation oncologists of India for radiation therapy patients and staff among COVID 19 pandemic

39 Evaluation of a PCR assay for detection of Streptococcus pneumoniae in respiratory and nonrespiratory samples from adults with community-acquired pneumonia

40 Evaluation of the immunochromatographic Binax NOW assay for detection of Streptococcus pneumoniae urinary antigen in a prospective study of community-acquired pneumonia in Spain

41 Diagnostic value of microscopic examination of Gram-stained sputum and sputum cultures in patients with bacteremic pneumococcal pneumonia

42 Speculation on pathogenesis in death from respiratory syncytial virus infection

43 Experimental respiratory syncytial virus pneumonia in cebus monkeys

44 Spectrum of disease in persons with human immunodeficiency virus infection in the United States

45 Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in The Gambia: randomised, double-blind, placebo-controlled trial

46 [Expert consensus on prevention and treatment strategies for osteonecrosis of femoral head during the prevention and control of novel coronavirus pneumonia (2020)]

47 Rapid urinary antigen test for diagnosis of pneumococcal community-acquired pneumonia in adults

48 Clinical profile of serologically diagnosed pneumococcal pneumonia

49 Virus-specific IgE and IgG4 antibodies in serum of children infected with respiratory syncytial virus

50 Pathological features of COVID-19 infection from biopsy and autopsy series

51 Assessment of analysis of urinary pneumococcal antigen by immunochromatography for etiologic diagnosis of community-acquired pneumonia in adults

52 Contribution of a pleural antigen assay (Binax NOW) to the diagnosis of pneumococcal pneumonia

53 Quantitative detection of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in lower respiratory tract samples by real-time PCR

54 Severe COVID-19 in the young and healthy: monogenic inborn errors of immunity?

55 Respiratory syncytial virus (RSV) immune globulin intravenous therapy for RSV lower respiratory tract infection in infants and young children at high risk for severe RSV infections: Respiratory Syncytial Virus Immune Globulin Study Group

56 Efficacy, safety, and therapeutic relevance of transthoracic aspiration with ultrathin needle in nonventilated nosocomial pneumonia

57 Eosinophil degranulation in the respiratory tract during naturally acquired respiratory syncytial virus infection

58 Salmonella, Campylobacter and Shigella in HIV-seropositive patients

59 COVID-19 pandemic: Radiotherapy precautions and preparedness

60 Epidemiology of respiratory syncytial virus infection in Washington, D.C. II. Infection and disease with respect to age, immunologic status, race and sex

61 Usefulness of the Streptococcus pneumoniae urinary antigen test in the treatment of community-acquired pneumonia

62 Antibiotic treatment and the diagnosis of Streptococcus pneumoniae in lower respiratory tract infections in adults

63 Asthma and COVID-19: What do we know?

64 Evaluation of Binax NOW, an assay for the detection of pneumococcal antigen in urine samples, performed among pediatric patients

65 Latex agglutination test for diagnosing pneumococcal pneumonia in children in developing countries

66 The NOW S. pneumoniae urinary antigen test positivity rate 6 weeks after pneumonia onset and among patients with COPD

67 Pharmacodynamics of levofloxacin and ciprofloxacin in a murine pneumonia model: peak concentration/MIC versus area under the curve/MIC ratios

68 Prospective study to determine clinical relevance of detection of pneumococcal DNA in sera of children by PCR

69 [COVID-19: A neurological point-of-view]

70 The value of signs and symptoms in differentiating between bacterial, viral and mixed aetiology in patients with community-acquired pneumonia

71 parallel colorimetric quantification of choline and phosphocholine as a method for studying choline kinase activity in complex mixtures

72 Survival in children with perinatally acquired human immunodeficiency virus type 1 infection

73 Home management of mild to moderately severe community-acquired pneumonia: a randomised controlled trial

74 Pneumococcal coinfection with human metapneumovirus

75 Straining the System: Novel Coronavirus (COVID-19) and Preparedness for Concomitant Disasters

76 Study of community acquired pneumonia aetiology (SCAPA) in adults admitted to hospital: implications for management guidelines

77 Baricitinib as potential treatment for 2019-nCoV acute respiratory disease

78 COVID-19: combining antiviral and anti-inflammatory treatments

79 Effect of High vs Low Doses of Chloroquine Diphosphate as Adjunctive Therapy for Patients Hospitalized With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection: A Randomized Clinical Trial

80 Clinical characteristics of 24 asymptomatic infections with COVID-19 screened among close contacts in Nanjing, China

81 Impact of COVID-19 on people with cystic fibrosis

82 Bacterial coinfections in lung tissue specimens from fatal cases of 2009 pandemic influenza A (H1N1) - United States, May-August 2009

83 Association Between Hospitalization With Community-Acquired Laboratory-Confirmed Influenza Pneumonia and Prior Receipt of Influenza Vaccination

84 Estimation of the reproductive number of novel coronavirus (COVID-19) and the probable outbreak size on the Diamond Princess cruise ship: A data-driven analysis

85 Microbial etiology of community-acquired pneumonia in the adult population of 4 municipalities in eastern Finland

86 Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine in adults 70 years of age and older previously vaccinated with 23-valent pneumococcal polysaccharide vaccine

87 Incidence and characteristics of viral community-acquired pneumonia in adults

88 Low incidence of COVID-19 in children and adolescent post-liver transplant at a Latin American reference center

89 The effectiveness of pneumococcal polysaccharide vaccine 23 (PPV23) in the general population of 50 years of age and older: A systematic review and meta-analysis

90 Quantitative detection of Streptococcus pneumoniae from sputum samples with real-time quantitative polymerase chain reaction for etiologic diagnosis of community-acquired pneumonia

91 The COVID-19 Pandemic from an Ophthalmologist's Perspective

92 The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients

93 The pathology of influenza virus infections

94 ACE inhibitor and swallowing reflex

95 Oral care reduces pneumonia in older patients in nursing homes

96 Polysaccharide conjugate vaccine against pneumococcal pneumonia in adults

97 Respiratory viral infections in adults with hematologic malignancies and human stem cell transplantation recipients: a retrospective study at a major cancer center

98 Viral community-acquired pneumonia in nonimmunocompromised adults

99 A Case Series of Children With 2019 Novel Coronavirus Infection: Clinical and Epidemiological Features

100 COVID-19 and Nasal Cytobrush Cytology

101 Smell and taste dysfunction in patients with COVID-19

Keyword Connections

Journals

Research Groups

Bibliographies